Peter M. Hecht

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Peter M. Hecht
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Peter M. Hecht

Form 4 holding Director, 10%+ Owner

Cyclerion Therapeutics, Inc.

Security class
Common Stock
Shares / value
559,203
Estimated value
$1,537,808
Report date
25 Mar 2025
Price
$2.75
Ownership
Direct
Form 4 holding Director, 10%+ Owner

Cyclerion Therapeutics, Inc.

Security class
Common Stock
Shares / value
24
Estimated value
$66
Report date
25 Mar 2025
Price
$2.75
Ownership
The 2000 Trust for Alexis Mae Hecht
Form 4 holding Director, 10%+ Owner

Cyclerion Therapeutics, Inc.

Security class
Common Stock
Shares / value
24
Estimated value
$66
Report date
25 Mar 2025
Price
$2.75
Ownership
The 2000 Trust for Malcolm Peter Hecht
Form 4 holding Director, 10%+ Owner

Cyclerion Therapeutics, Inc.

Security class
Common Stock
Shares / value
24
Estimated value
$66
Report date
25 Mar 2025
Price
$2.75
Ownership
The 2000 Trust for Zoe Niovi Hecht

Insider Reports Filed by Peter M. Hecht

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .